Details for 2019192281
Up to date per 01.04.2026
Actions
Details for 2019192281
Deleted
European Patent
27.05.2020 A
20.04.2022 B1
21.06.2011
US
201161499620 P
25.04.2012
US
201261638288 P
C12N 15/113 20100101AFI20211029BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
No representatives present
Inventor
BETTENCOURT, Brianc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US
QUERBES, Williamc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US
FITZGERALD, Kevinc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US
FRANK-KAMENETSKY, Mariac/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US
MILSTEIN, Stuartc/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US
SHULGA-MORSKAYA, Svetlanac/o Alnylam Pharmaceuticals, Inc. 300 Third Street, 3rd Floor Cambridge, MA 02142US